Cadila Pharmaceuticals

For over seven decades, Cadila Pharma has been a pioneer of India’s pharmaceutical journey. Guided by the vision “Care Continues”, our Branded Generics business combines scientific innovations and breakthroughs with manufacturing excellence and ethical responsibility to improve health outcomes across India and add hope to people’s lives.

Our branded generic business is strategically structured across three core segments – Innovations, Branded Generics, and Generics Business to address diverse therapeutic needs throughout the patient’s journey.

We offer solutions across both acute and chronic therapy. Our Acute Therapy focuses on rapid intervention and short-term treatment, while our acute portfolio supports effective clinical outcomes across gastro care, respiratory care, infectious disease management, pain & inflammation management, and overall health and well-being.

Our Chronic Therapies are designed for long-term disease management. Our chronic portfolio supports continuity of care across cardiac care, diabetes care, neuro care, onco care, women's health care, osteoporosis and osteopenia management, and other lifestyle disorder management.

Innovations
Innovations
We continue to lead with innovation, advancing global healthcare through first-in-the-world drug breakthroughs and a robust R&D engine.
Branded Generics
Branded Generics
Cadila Pharma’s Branded Generics is more than just a portfolio. It is a commitment to care that continues, trust that ensures and innovation that matters.
(Domestic & International)
Generic Business
Generic Business
Our generic segment offers a vast range of high-quality, affordable medicines in India, the USA, Europe, and emerging markets.
(Domestic & International)

Product NameCompositionSal-pack
Loading...
downWhiteCurveArrow

Corporate Identification No : U24231GJ1991PLC015132

©2026 Cadila Pharmaceuticals. All rights reserved